Thyrocare Technologies
BSE: 539871 | NSE: THYROCARE | ISIN: INE594H01019 | SECTOR: Healthcare FacilitiesOpen
612.40High
645.75Low
605.00Prev Close
616.40P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
33.62BVolume
9.30KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
-Ask
-
Promoter Pledge Holding - 71.11%
Promoter Name | No of Shares | Percentage |
---|---|---|
Docon Technologies Private Limited | 3,76,56,092 | 71.11% |
Company Description
- Healthcare Facilities
BSE
539871NSE
THYROCAREISIN
INE594H01019
Thyrocare Technologies Limited is an India-based healthcare services provider in diagnostic area. The Company has diagnostic chains that conduct a range of medical diagnostic tests and profiles of tests that is focused on early detection and management of health disorders and diseases. The Company's segments include Diagnostic Testing Services, Imaging Services and Others. The Diagnostic Testing Services segment includes diagnostic and testing services, selling of consumables used for collection and promotion of pathology. The Imaging Services includes diagnostic and imaging services, selling of radio-pharmaceutical, selling of consumables for reporting. The Others segment include the sale of testing equipment and consumables, and selling of glucometer and glucostrips under the brand, Sugarscan. The Company has a centralized fully automated diagnostic testing laboratory, regional processing laboratories, a medical cyclotron facility and PET-CT facilities across India.
Company Officers
Rahul Guha
Executive Chairman of the Board, Chief Executive Officer, Managing Director, Executive Director, President - OperationsAlok Jagnani
Chief Financial OfficerKallathikumar K
Chief Operating OfficerRamjee Dorai
Chief Compliance Officer, Company SecretaryAditya Shinde
Vice President - FinanceCaesar Sengupta
Vice President - OperationsS. Krishnakumar
General Manager - LabRetheesh Pillai
General ManagerAnkit Brijpuriya
Deputy Company Secretary and Deputy Compliance OfficerNitin Chugh
Chief Commercial Officer